Stock 300534 GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Equities

300534

CNE100002CP5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
7.76 CNY -3.36% Intraday chart for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD -6.28% -21.38%
05-17 Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager MT
04-26 Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is a company mainly engaged in research and development, production and sales of Chinese traditional medicine. The Company operates two segments. The Pharmaceutical Manufacturing segments is involved in the production and sale of Chinese traditional medicine, health food and raw materials. Its primary product is Yuanhuzhitong dripping pills, which is used for the treatment of stomach pain, rib pain and headache. The Company also produces other drugs, including compound salvia miltiorrhiza tablets, anti-inflammatory and gallbladder tablets, as well as Sanqi injury tablets. The Sales and Logistics segment operates logistics and distribution business.

Number of employees: 763

Sales per Business

CNY in Million2022Weight2023Weight Delta
Mixtures
60.0 %
- - 648 60.0 % -
Dropping Pills
22.1 %
263 63.7 % 239 22.1 % -9.38%
Logistics and Distribution
9.2 %
104 25.1 % 99 9.2 % -3.96%
Medical Devices and Others
7.0 %
- - 76 7.0 % -
House Rental
0.8 %
7 1.7 % 9 0.8 % +26.21%
Tablets
0.2 %
2 0.6 % 3 0.2 % +8.01%
Supply Enquiry
0.2 %
1 0.3 % 2 0.2 % +83.46%
Raw Materials
0.2 %
0 0.0 % 2 0.2 % +1,611.83%
Processing
0.1 %
- - 1 0.1 % -
Capsules
0.1 %
0 0.1 % 1 0.1 % +244.08%
Pharmaceutical Intermediates
0.1 %
- - 1 0.1 % -
Scrap Sales
0.0 %
- - 0 0.0 % -
Material Sales
0.0 %
- - 0 0.0 % -
Film Type
0.0 %
0 0.0 % 0 0.0 % +62.41%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.2 %
403 97.5 % 1,071 99.2 % +165.89%
Foreign
0.8 %
10 2.5 % 9 0.8 % -16.08%

Managers

Managers TitleAgeSince
Shuang Xi Qian CEO
 Chief Executive Officer 39 23-03-09
Zheng Choi Zhao DFI
 Director of Finance/CFO 37 09-06-30
Yong Hong Kang BRD
 Director/Board Member 48 02-06-02
Qin Hui Yuan BRD
 Director/Board Member 49 12-11-28
Shou Bing Xue IRC
 Investor Relations Contact - -
Yao Wu Chen PRN
 Corporate Officer/Principal 42 20-08-20

Members of the board

Members of the board TitleAgeSince
Qin Hui Yuan BRD
 Director/Board Member 49 12-11-28
Zong Yi Li BRD
 Director/Board Member 54 20-12-29
Kan Ren Zhou BRD
 Director/Board Member 48 17-11-09
Zheng Choi Zhao DFI
 Director of Finance/CFO 37 09-06-30
Yi Jie Ren BRD
 Director/Board Member 43 19-03-20
Min Ping Song CHM
 Chairman 60 22-04-25
Jian Jun Li BRD
 Director/Board Member 58 20-12-29
Hong Hai Liu BRD
 Director/Board Member 50 20-12-29
Zhen Luo BRD
 Director/Board Member 54 21-01-17
Bo Sun BRD
 Director/Board Member 38 20-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 303,345,000 181,716,245 ( 59.90 %) 0 59.90 %

Shareholders

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
0.1392 %
263,200 0.1392 % 299 127 ¥
Wanjia Asset Management Co., Ltd.
0.0804 %
152,100 0.0804 % 172 862 ¥
Hui'an Fund Management Co. Ltd.
0.0627 %
118,600 0.0627 % 134 789 ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.0242 %
45,800 0.0242 % 52 052 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0135 %
25,600 0.0135 % 29 094 ¥
HFT Investment Management Co., Ltd.
0.009626 %
18,200 0.009626 % 20 684 ¥
Broad Fund Management Co. Ltd.
0.009308 %
17,600 0.009308 % 20 002 ¥
Golden Eagle Asset Management Co., Ltd.
0.008885 %
16,800 0.008885 % 19 093 ¥
Bosera Asset Management Co., Ltd.
0.003702 %
7,000 0.003702 % 7 956 ¥
Zhejiang Zheshang Securities Asset Management Co., Ltd.
0.001164 %
2,200 0.001164 % 2 500 ¥

Company contact information

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

10 Guofang Road Dingyuan Town

730102, Lanzhou

+

http://www.lsrfzy.com
address Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD(300534)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD Stock Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
-21.38% 336M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.46% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.05% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.27% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.75% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.07% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300534 Stock
  4. Company Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD